Shelby Fisher

RTI International, United States

Disclosure information not submitted.

Presentation(s):

• Risk of Neurologic or Immune-Mediated Adverse Events After COVID-19 Diagnosis in the United States

  Wednesday, August 28, 2024
  1:30 PM – 1:45 PM CEST

• Risk of Cardiovascular Adverse Events After COVID-19 Diagnosis in the United States

  Wednesday, August 28, 2024
  2:45 PM – 3:00 PM CEST